Catherine Faber

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation

Hai Xu, Catherine Faber, Tomoaki Uchiki et al. · Proceedings of the National Academy of Sciences · 2006 · 80 citations · Full text

Aldo-keto Reductase, Molecular Regulation, Molecular Biology +16

Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly

Hai Xu, Catherine Faber, Tomoaki Uchiki et al. · Proceedings of the National Academy of Sciences · 2006 · 69 citations · Full text

Responses of brown adipose tissue to diet-induced obesity, exercise, dietary restriction and ephedrine treatment

Nikki Slocum, Jessica Durrant, David Bailey et al. · Experimental and Toxicologic Pathology · 2012 · 63 citations

Nutrition, Metabolic Disorder, Caloric Restriction +16

Three-dimensional structure of a human Fab with high affinity for tetanus toxoid

Catherine Faber, Lin Shan, Zhao-chang Fan et al. · Immunotechnology · 1998 · 48 citations

Tetanus Toxoid, Developmental Biology, Three-dimensional Structure +6